How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?

Author： Schackman B.R.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.5, 2004-01, pp. : 293-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-benefit or cost-utility analysis?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Is the use of the `transfer to utility' method valid in economic analyses?

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

How often do false-positive phencyclidine urine screens occur with use of common medications?*

By Rengarajan Arvind   Mullins Michael E.  

Clinical Toxicology, Vol. 51, Iss. 6, 2013-07 ,pp. : 493-496

Informa Healthcare

Access to resources Recommend Favorite

Validity of Cost and Utility Results?

By Diamantopoulos Alex  

PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. : 977-977

Adis International

Access to resources Recommend Favorite

How does cost effectiveness change over a product's life cycle?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite